₹692.10
+₹13.95 (+2.06%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹8,310 Cr
P/E
39.48
ROE
11.12%
ROCE
11.64%
About Medplus Health Services Ltd
Medplus Health Services is primarily engaged in the business of provision of diagnostic services pathological services and laboratory testing services.
Founded
2006
CEO
GANGADI MADHUKAR REDDY
Employees
25,007
HQ
Hyderabad, Telangana
About Medplus Health Services Ltd
Medplus Health Services is primarily engaged in the business of provision of diagnostic services pathological services and laboratory testing services.
Founded:2006
CEO:GANGADI MADHUKAR REDDY
Employees:25,007
HQ:Hyderabad, Telangana
Finished Products
1Sales
₹973.14Cr2Sale of services
₹182.99Cr3Adjustment - Discounts
₹61.68Cr4Discount
₹38.13Cr5Other operating revenue
₹11.87Cr6Branding Fees
₹8.87Cr7Management and administrative
₹3.25CrRaw Materials
1Purchases of stock-in-trade
₹793.42Cr2Cost of materials Consumed
₹106.14CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹1,022
52W Low
₹648
Volume153.25K
Avg VolumeN/A
Beta0.50
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
39.48x
Valuation
P/B Ratio
4.21x
Valuation
EPS
₹17.52
Valuation
Dividend Yield
0.00%
Valuation
ROE
11.12%
Profitability
ROCE
11.64%
Profitability
Revenue by Segment
Contribution & growth by business line
Retail
+8.7%98.2%
₹5,978.3 Cr
Diagnostics
+44.4%1.8%
₹108.11 Cr
Others
+15.2%0.0%
₹1.06 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.72x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
7.0%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.